With both MDT & ABT focusing on their core strengths, the stage is set for a compelling comparison. Let's see which stock is ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” first quarter ...

Notably, Abbott is a member of the S&P 500 Dividend ... healthcare stocks, of 14.41X, below its 5-year median of 16.19X and pretty close to the 5-year low of 13.13X. Meanwhile, ABT is presently ...

Abbott Laboratories (NYSE:ABT) is an American multinational ... dividend of $0.59 per share and has a dividend yield of 1.75%, as of May 18. The stock surged by over 30.6% in the past 12 months.

Citing what they call the S&P 500 price-to-earnings mania, Stifel is once again recommending that what it calls “defensive ...

These four Dividend Aristocrats have far outperformed the S&P 500 so far this year, but they still offer investors good entry ...

Abbott boasts strong profitability, stable margins, and impressive long-term growth, but recent sales have stagnated. Check ...

Dividend-paying stocks are drawing increased attention from ... Abbott Laboratories (NYSE:ABT) is an American multinational medical device and healthcare company. The company recently shared ...

Abbott Laboratories (NYSE:ABT) recently shared findings from its REFLECT real-world studies, revealing that the use of its ...

Abbott is marching to the beat of a very profitable drum, driven by cardiac care dominance, nutrition brand power, and ...